The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
MMA CAP MGMT LLC COM 55315D105 1,763 72,552 SH   SOLE   72,552 0 0
ONCONOVA THERAPEUTICS INC COM NEW 68232V306 1,496 997,022 SH   SOLE   997,022 0 0
ONCONOVA THERAPEUTICS INC *W EXP 07/07/202 68232V116 215 390,624 SH   SOLE   390,624 0 0